《大行》野村升潤啤(00291.HK)目標價至44.6元 基本面在同行中最穩健
野村發表研究報告指,華潤啤酒(00291.HK)上半年整體業績表現穩健,收入按年增1%;銷售升2.2%;均價升0.4%,顯示在潤啤的高端化策略下,啤酒業務市場份額持續增長。另外,期內公司及其啤酒業務的毛利率爲48.9%和48.3%,分別按年增2及2.5個百分點,派中期息0.464元人民幣。
該行認爲,潤啤的基本面在中國啤酒行業中仍然是最穩健的公司。該行上調華潤啤酒2025至2026財年的盈測9至11%,以反映中期利潤勝於預期,重申其「買入」評級,目標價由40.9元調升至44.6元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.